Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Brighthouse Financial, Inc.BHF · Entity 1737 | EVP & Chief Operating Officer | May 23, 2018 | May 25, 2018 |
| CITIZENS, INC.CIA · Entity 6336 | Director | June 17, 2026 | June 22, 2026 |
| METLIFE INCMET · Entity 488 | EVP & Chief Accounting Officer | March 01, 2017 | March 03, 2017 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Chief Financial Officer | May 10, 2023 | May 12, 2023 |
| Spectral AI, Inc.MDAI · Entity 7203 | Director · Chief Executive Officer | May 10, 2024 | May 13, 2024 |
| WHITE MOUNTAINS INSURANCE GROUP LTDWTM · Entity 3904 | Director | May 21, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Brighthouse Financial, Inc.
Report date May 23, 2018 · Filed May 25, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 44,004 |
Reported balance
After 2018-05-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-23 · Grant · Acquired 44,004 · Balance 44,004 F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Brighthouse Financial, Inc. ("BHF") common stock. F2: The award of RSUs was authorized on August 9, 2017, to be effective on September 8, 2017. The award was subject to approval by stockholders of BHF of the Brighthouse Financial, Inc. 2017 Stock and Incentive Compensation Plan (the "Employee Plan"). The Employee Plan was approved by stockholders of BHF on May 23, 2018. F3: The RSUs will vest on September 30, 2018. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,480 |
Reported balance
After 2018-05-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-05-23 · Grant · Acquired 7,480 · Balance 7,480 F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Brighthouse Financial, Inc. ("BHF") common stock. F4: RSU and Stock Option awards were authorized on February 16, 2018, to be effective on March 1, 2018. These awards were subject to approval by stockholders of BHF of the Employee Plan, which was obtained on May 23, 2018. F5: The RSUs will vest in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.47 · Expires 2028-02-29 | Direct | 24,570 |
Reported balance
After 2018-05-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-23 · Grant · Acquired 24,570 · Balance 24,570 F4: RSU and Stock Option awards were authorized on February 16, 2018, to be effective on March 1, 2018. These awards were subject to approval by stockholders of BHF of the Employee Plan, which was obtained on May 23, 2018. F6: The Stock Options become exercisable in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Brighthouse Financial, Inc. ("BHF") common stock.
F2: The award of RSUs was authorized on August 9, 2017, to be effective on September 8, 2017. The award was subject to approval by stockholders of BHF of the Brighthouse Financial, Inc. 2017 Stock and Incentive Compensation Plan (the "Employee Plan"). The Employee Plan was approved by stockholders of BHF on May 23, 2018.
F3: The RSUs will vest on September 30, 2018.
F4: RSU and Stock Option awards were authorized on February 16, 2018, to be effective on March 1, 2018. These awards were subject to approval by stockholders of BHF of the Employee Plan, which was obtained on May 23, 2018.
F5: The RSUs will vest in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.
F6: The Stock Options become exercisable in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.
CITIZENS, INC.
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Citizens, Inc. Class A Common StockSEC Table I · non-derivative | Direct | 12,012 |
Reported balance
After 2026-06-17 transaction · row 1
1 source rowRow 1 · 2026-06-17 · Exercise / conversion · Acquired 12,012 · Balance 12,012 F1: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-17 · Exercise / conversion · Disposed 12,012 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. F2: On June 17, 2025, the reporting person was granted 12,012 restricted stock units, vesting on June 17, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,042 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Grant · Acquired 7,042 · Balance 7,042 F1: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. F3: On June 17, 2026, the reporting person was granted 7,042 restricted stock units, vesting on June 17, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock.
F2: On June 17, 2025, the reporting person was granted 12,012 restricted stock units, vesting on June 17, 2026.
F3: On June 17, 2026, the reporting person was granted 7,042 restricted stock units, vesting on June 17, 2027.
METLIFE INC
Report date March 01, 2017 · Filed March 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,558 |
Ending reported balance
After 2017-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-03-01 · Exercise / conversion · Acquired 1,735 · Balance 35,200 F1: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Row 2 · 2017-03-01 · Tax withholding · Disposed 642 · Balance 34,558 F2: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share unit payout. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,471 |
Reported balance
After 2017-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-03-01 · Exercise / conversion · Disposed 1,735 · Balance 3,471 F1: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.
F2: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share unit payout.
F3: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier.
MIMEDX GROUP, INC.
Report date May 10, 2023 · Filed May 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 656,435 |
Reported balance
After 2023-05-10 transaction · row 1
1 source rowRow 1 · 2023-05-10 · Sale · Disposed 5,976 · Balance 656,435 F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
Spectral AI, Inc.
Report date May 10, 2024 · Filed May 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,411 |
Reported balance
After 2024-05-10 transaction · row 1
1 source rowRow 1 · 2024-05-10 · Grant · Acquired 29,411 · Balance 29,411 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2024-01-03 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2024-05-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 150,000 F2: 50% of RSUs vest on a time-based vesting schedule with 33% of the RSUs vesting on 1/3/2025, 33% vest on 1/3/2026, and the remainder vest on 1/3/2027. The remainder vest pursuant to certain performance-based metrics. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2024-02-29 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2024-05-10 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 150,000 F3: 50% of RSUs vest on a time-based vesting schedule with 33% of the RSUs vesting on 2/28/2025, 33% vest on 2/28/2026, and the remainder vest on 2/28/2027. The remainder vest pursuant to certain performance-based metrics. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: 50% of RSUs vest on a time-based vesting schedule with 33% of the RSUs vesting on 1/3/2025, 33% vest on 1/3/2026, and the remainder vest on 1/3/2027. The remainder vest pursuant to certain performance-based metrics.
F3: 50% of RSUs vest on a time-based vesting schedule with 33% of the RSUs vesting on 2/28/2025, 33% vest on 2/28/2026, and the remainder vest on 2/28/2027. The remainder vest pursuant to certain performance-based metrics.
WHITE MOUNTAINS INSURANCE GROUP LTD
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 852 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 135 · Balance 852 F1: Annual Director Share Award |
Filing footnotes · ownership attribution and instrument terms
F1: Annual Director Share Award
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 22, 2026 15:23 UTC | CITIZENS, INC. CIA · Entity 6336 | GrantRestricted Stock Units · Derivative | 7,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001379320-26-000002 · wk-form4_1782141808.xml · derivative · entry 3 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,042 Underlying: Class A Common Stock · 7,042 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. F3 · derivative.exercise_date: On June 17, 2026, the reporting person was granted 7,042 restricted stock units, vesting on June 17, 2027. F3 · derivative.expiration_date: On June 17, 2026, the reporting person was granted 7,042 restricted stock units, vesting on June 17, 2027. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 15:23 UTC | CITIZENS, INC. CIA · Entity 6336 | Exercise / conversionRestricted Stock Units · Derivative | 12,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001379320-26-000002 · wk-form4_1782141808.xml · derivative · entry 2 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Citizens, Inc. Class A Common Stock · 12,012 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. F2 · derivative.exercise_date: On June 17, 2025, the reporting person was granted 12,012 restricted stock units, vesting on June 17, 2026. F2 · derivative.expiration_date: On June 17, 2025, the reporting person was granted 12,012 restricted stock units, vesting on June 17, 2026. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 15:23 UTC | CITIZENS, INC. CIA · Entity 6336 | Exercise / conversionCitizens, Inc. Class A Common Stock | 12,012 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001379320-26-000002 · wk-form4_1782141808.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. Read SEC document |
| May 21, 2026 Filed May 22, 2026 14:31 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 135 | $0.00 | $0.00 |
DisclosureSEC source: 0000776867-26-000037 · form4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 852 F1 · shares: Annual Director Share Award Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 17:02 UTC | CITIZENS, INC. CIA · Entity 6336 | GrantRestricted Stock Units · Derivative | 12,012 | $0.00 | $0.00 |
DisclosureSEC source: 0000024090-25-000100 · wk-form4_1750438916.xml · derivative · entry 2 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Citizens, Inc. Class A Common Stock · 12,012 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Citizens, Inc. Class A common stock. F2 · derivative.exercise_date: On June 17, 2025, the reporting person was granted 12,012 restricted stock units, vesting on June 17, 2026. F2 · derivative.expiration_date: On June 17, 2025, the reporting person was granted 12,012 restricted stock units, vesting on June 17, 2026. Read SEC document |
| May 22, 2025 Filed May 23, 2025 23:09 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010296 · form4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 717 F1 · shares: Annual Director Share Award F2 · balance_after: Since the date of the reporting person's last ownership report, he transferred 566 shares of WTM common stock in connection with a dissolution of marriage. The reporting person no longer reports as beneficially owned any such transferred securities. Read SEC document |
| May 23, 2024 Filed May 24, 2024 16:14 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011186 · form4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,133 F1 · shares: Annual Director Share Award Read SEC document |
| May 10, 2024 Filed May 13, 2024 21:21 UTC | Spectral AI, Inc. MDAI · Entity 7203 | GrantCommon Stock | 29,411 | $1.74 | $51,175.14 |
DisclosureSEC source: 0001213900-24-042421 · ownership.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,411 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 25, 2023 Filed May 30, 2023 15:15 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012413 · form4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 968 F1 · shares: Annual Director Share Award Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:50 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 5,976 | $5.93 | $35,414.37 |
DisclosureSEC source: 0001376339-23-000024 · wf-form4_168393180333729.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,435 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 23:21 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 6,094 | $3.74 | $22,815.94 |
DisclosureSEC source: 0001379320-23-000006 · wf-form4_168263769899412.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662,411 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 21:37 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 6,100 | $3.31 | $20,191.00 |
DisclosureSEC source: 0001379320-23-000005 · wf-form4_168142185706673.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668,505 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 22:21 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 140,455 | $4.62 | $648,902.10 |
DisclosureSEC source: 0001379320-23-000004 · wf-form4_167891885113196.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 674,605 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 22:41 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 12,056 | $4.24 | $51,172.90 |
DisclosureSEC source: 0001379320-23-000003 · wf-form4_167840167243742.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,150 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 22:41 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 19,000 | $4.50 | $85,416.40 |
DisclosureSEC source: 0001379320-23-000002 · wf-form4_167727845960866.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,206 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $4.490 to $4.505, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein. Read SEC document |
| December 22, 2022 Filed Dec 28, 2022 00:55 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 4,992 | $2.82 | $14,052.98 |
DisclosureSEC source: 0001379320-22-000007 · wf-form4_167218891177832.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,206 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $2.810 to $2.8159, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 23:02 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | SaleCommon Shares | 200 | $1,400.00 | $280,000.00 |
DisclosureSEC source: 0001062993-22-019881 · form4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788 Read SEC document |
| May 26, 2022 Filed May 27, 2022 16:54 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-013662 · form4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988 F1 · shares: Annual WTM Director Share Award Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 21:25 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 187,500 | $4.62 | $866,250.00 |
DisclosureSEC source: 0001376339-22-000039 · wf-form4_164979872433149.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,198 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 10,743 | $4.86 | $52,200.24 |
DisclosureSEC source: 0001376339-22-000023 · wf-form4_164694760057391.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,698 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:06 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 17,400 | $4.83 | $84,078.54 |
DisclosureSEC source: 0001376339-22-000009 · wf-form4_164616879224210.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,441 F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.81 to $4.87, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:05 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 13,274 | $12.26 | $162,739.24 |
DisclosureSEC source: 0001379320-21-000006 · wf-form4_162767551630263.xml · nonDerivative · entry 2 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,841 F2 · shares: Represents shares withheld to pay associated taxes upon vesting. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:05 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 35,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001379320-21-000006 · wf-form4_162767551630263.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,115 F1 · shares: Represents satisfaction of performance criterion with respect to previously-granted performance-vested restricted stock units. Read SEC document |
| May 27, 2021 Filed May 28, 2021 21:41 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001668244-21-000024 · edgar.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763 F1 · shares: Annual WTM Director Share Award Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:15 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 109,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001379320-21-000004 · wf-form4_161523812702406.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,903 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 19:55 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 18,015 | $9.81 | $176,727.15 |
DisclosureSEC source: 0001379320-21-000002 · wf-form4_161402374087589.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,668 F1 · acquired: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| November 04, 2020 Filed Nov 5, 2020 21:04 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 35,211 | $7.23 | $254,575.53 |
DisclosureSEC source: 0001379320-20-000006 · wf-form4_160461022643688.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,683 F1 · date: Represents vesting upon satisfaction of performance criterion with respect to previously-granted performance based restricted stock units. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:52 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 177,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001379320-20-000004 · wf-form4_159674714591635.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,472 F1 · price: On August 5, 2020, the Company fixed the number of shares subject to previously-awarded restricted units based on the closing stock price on that date ($5.90). Award will be settled in common stock upon vesting. One-third of the award vests upon each anniversary of the original grant date, February 18, 2020. Grant is exempt under rule 16b-3. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:47 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 35,211 | $5.40 | $190,139.40 |
DisclosureSEC source: 0001379320-20-000002 · wf-form4_159415483364541.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,506 F1 · shares: Reflects the satisfaction of performance criterion of grant made on December 16, 2019 Read SEC document |
| May 21, 2020 Filed May 22, 2020 20:01 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001668244-20-000012 · edgar.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538 F1 · shares: Annual WTM Director Share Award Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 16:42 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 49,295 | $7.10 | $349,994.50 |
DisclosureSEC source: 0001379320-19-000006 · wf-form4_157668732160769.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · EVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,295 F1 · kind: Represents grant of restricted stock which vests one-third on each anniversary. Read SEC document |
| May 23, 2019 Filed May 28, 2019 21:23 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001668244-19-000031 · edgar.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313 F1 · shares: Annual WTM Director Share Award Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 14:45 UTC | WHITE MOUNTAINS INSURANCE GROUP LTD WTM · Entity 3904 | GrantCommon Shares | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001668244-19-000007 · edgar.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · shares: Pro-rated annual WTM Director Share Award Read SEC document |
| May 23, 2018 Filed May 25, 2018 12:12 UTC | Brighthouse Financial, Inc. BHF · Entity 1737 | GrantEmployee Stock Option (Right to Buy) · Derivative | 24,570 | $0.00 Strike: $53.47 | $0.00 |
DisclosureSEC source: 0001209191-18-033265 · doc4.xml · derivative · entry 3 Carlson Peter M · CIK 0001379320 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,570 Underlying: Common Stock · 24,570 shares Expires 2028-02-29 F4 · shares: RSU and Stock Option awards were authorized on February 16, 2018, to be effective on March 1, 2018. These awards were subject to approval by stockholders of BHF of the Employee Plan, which was obtained on May 23, 2018. F6 · derivative.exercise_date: The Stock Options become exercisable in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| May 23, 2018 Filed May 25, 2018 12:12 UTC | Brighthouse Financial, Inc. BHF · Entity 1737 | GrantRestricted Stock Units · Derivative | 7,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033265 · doc4.xml · derivative · entry 2 Carlson Peter M · CIK 0001379320 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,480 Underlying: Common Stock · 7,480 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Brighthouse Financial, Inc. ("BHF") common stock. F4 · shares: RSU and Stock Option awards were authorized on February 16, 2018, to be effective on March 1, 2018. These awards were subject to approval by stockholders of BHF of the Employee Plan, which was obtained on May 23, 2018. F5 · derivative.exercise_date: The RSUs will vest in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. F5 · derivative.expiration_date: The RSUs will vest in three substantially equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| May 23, 2018 Filed May 25, 2018 12:12 UTC | Brighthouse Financial, Inc. BHF · Entity 1737 | GrantRestricted Stock Units · Derivative | 44,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033265 · doc4.xml · derivative · entry 1 Carlson Peter M · CIK 0001379320 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,004 Underlying: Common Stock · 44,004 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Brighthouse Financial, Inc. ("BHF") common stock. F2 · shares: The award of RSUs was authorized on August 9, 2017, to be effective on September 8, 2017. The award was subject to approval by stockholders of BHF of the Brighthouse Financial, Inc. 2017 Stock and Incentive Compensation Plan (the "Employee Plan"). The Employee Plan was approved by stockholders of BHF on May 23, 2018. F3 · derivative.exercise_date: The RSUs will vest on September 30, 2018. F3 · derivative.expiration_date: The RSUs will vest on September 30, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017471 · doc4.xml · derivative · entry 3 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,471 Underlying: Common Stock · 1,735 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments on the first business day of March 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 642 | $54.33 | $34,879.86 |
DisclosureSEC source: 0001209191-17-017471 · doc4.xml · nonDerivative · entry 2 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,558 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share unit payout. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:17 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-017471 · doc4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:45 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 3,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016687 · doc4.xml · derivative · entry 4 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,814 Underlying: Common Stock · 3,814 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments on the first business day in March 2018, 2019 and 2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments on the first business day in March 2018, 2019 and 2020. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:45 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,442 | $0.00 Strike: $52.44 | $0.00 |
DisclosureSEC source: 0001209191-17-016687 · doc4.xml · derivative · entry 3 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,442 Underlying: Common Stock · 11,442 shares Expires 2027-02-27 F3 · derivative.exercise_date: The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:45 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 1,191 | $52.44 | $62,456.04 |
DisclosureSEC source: 0001209191-17-016687 · doc4.xml · nonDerivative · entry 2 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,465 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:45 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 3,219 | $52.44 | $168,804.36 |
DisclosureSEC source: 0001209191-17-016687 · doc4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,656 F1 · kind: Shares acquired from the payout of the 2014-2016 Performance Share Award following determination of the performance factor for such award. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016562 · doc4.xml · derivative · entry 6 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The Restricted Stock Units vested in three equal installments on February 25, 2015, 2016 and 2017. This installment became payable following the certification on February 28, 2017 that MetLife, Inc. met specified financial goals. F4 · derivative.expiration_date: The Restricted Stock Units vested in three equal installments on February 25, 2015, 2016 and 2017. This installment became payable following the certification on February 28, 2017 that MetLife, Inc. met specified financial goals. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,257 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016562 · doc4.xml · derivative · entry 5 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,257 Underlying: Common Stock · 1,257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification on February 28, 2017 that MetLife, Inc. met specified financial goals. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification on February 28, 2017 that MetLife, Inc. met specified financial goals. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 439 | $52.49 | $23,043.11 |
DisclosureSEC source: 0001209191-17-016562 · doc4.xml · nonDerivative · entry 4 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,437 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share unit payout. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-016562 · doc4.xml · nonDerivative · entry 3 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 504 | $52.49 | $26,454.96 |
DisclosureSEC source: 0001209191-17-016562 · doc4.xml · nonDerivative · entry 2 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,667 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share unit payout. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:20 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-016562 · doc4.xml · nonDerivative · entry 1 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| December 23, 2016 Filed Dec 28, 2016 21:17 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionEmployee Stock Option (Right to Buy · Derivative | 13,636 | $0.00 Strike: $34.86 | $0.00 |
DisclosureSEC source: 0001209191-16-156889 · doc4.xml · derivative · entry 6 Carlson Peter M · CIK 0001379320 · EVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,636 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.